Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:19 pm Purchase | 2025-09-30 | 13G | PALVELLA THERAPEUTICS INC PVLA | BIOTECHNOLOGY VALUE FUND L P | 1,181,194 9.990% | 13,077 (+1.12%) | Filing History |
| 2025-11-14 4:17 pm Sale | 2025-09-30 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | BIOTECHNOLOGY VALUE FUND L P | 2,560,916 4.100% | -650,125 (-20.25%) | Filing History |
| 2025-11-14 4:14 pm Sale | 2025-09-30 | 13G | MIRUM PHARMACEUTICALS INC MIRM | BIOTECHNOLOGY VALUE FUND L P | 1,495,290 3.000% | -1,580,617 (-51.39%) | Filing History |
| 2025-11-14 4:12 pm Purchase | 2025-09-30 | 13G | KURA ONCOLOGY INC KURA | BIOTECHNOLOGY VALUE FUND L P | 8,677,018 9.990% | 2,764,464 (+46.76%) | Filing History |
| 2025-11-14 4:09 pm Purchase | 2025-09-30 | 13G | IMAGENEBIO, INC. IMA | BIOTECHNOLOGY VALUE FUND L P | 802,102 7.200% | 468,222 (+140.24%) | Filing History |
| 2025-11-14 4:08 pm Sale | 2025-09-30 | 13G | FORTE BIOSCIENCES INC FBRX | BIOTECHNOLOGY VALUE FUND L P | 65,350 0.500% | -578,272 (-89.85%) | Filing History |
| 2025-11-14 4:06 pm Sale | 2025-09-30 | 13G | CELCUITY INC CELC | BIOTECHNOLOGY VALUE FUND L P | 658,421 1.600% | -2,807,579 (-81.00%) | Filing History |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | BIOTECHNOLOGY VALUE FUND L P | 1,458,151 9.990% | 419,609 (+40.40%) | Filing History |
| 2025-11-10 5:27 pm Unchanged | 2025-11-06 | 13D | MOONLAKE IMMUNOTHERAPEUTICS CO MLTX | BIOTECHNOLOGY VALUE FUND L P | 19,751,284 27.700% | 0 (Unchanged) | Filing History |
| 2025-11-04 6:57 pm Purchase | 2025-10-31 | 13G | NEWCELX LTD SHS NCEL | BIOTECHNOLOGY VALUE FUND L P | 28,732 0.600% | 11,584 (+67.55%) | Filing History |
| 2025-10-29 5:24 pm Purchase | 2025-10-22 | 13G | COMPASS THERAPEUTICS INC CMPX | BIOTECHNOLOGY VALUE FUND L P | 8,750,000 5.100% | 8,750,000 (New Position) | Filing History |
| 2025-10-22 8:00 pm Purchase | 2025-10-15 | 13G | INVIVYD, INC. IVVD | BIOTECHNOLOGY VALUE FUND L P | 16,000,000 7.400% | 16,000,000 (New Position) | Filing History |
| 2025-10-17 4:56 pm Purchase | 2025-10-09 | 13G | XENCOR INC XNCR | BIOTECHNOLOGY VALUE FUND L P | 4,619,341 6.500% | 4,619,341 (New Position) | Filing History |
| 2025-10-17 4:48 pm Sale | 2025-10-15 | 13G | CIDARA THERAPEUTICS INC NE CDTX | BIOTECHNOLOGY VALUE FUND L P | 1,189,165 4.400% | -225,000 (-15.91%) | Filing History |
| 2025-10-17 4:45 pm Purchase | 2025-09-30 | 13G | CIDARA THERAPEUTICS INC NE CDTX | BIOTECHNOLOGY VALUE FUND L P | 1,414,165 5.200% | 161,724 (+12.91%) | Filing History |
| 2025-10-14 5:30 pm Sale | 2025-10-09 | 13D | ESSA PHARMA INC EPIX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -11,668,473 (Position Closed) | Filing History |
| 2025-08-20 5:41 pm Purchase | 2025-08-13 | 13G | X4 PHARMACEUTICALS INC XFOR | BIOTECHNOLOGY VALUE FUND L P | 2,243,659 9.900% | 2,168,379 (+2880.42%) | Filing History |
| 2025-08-18 5:02 pm Purchase | 2025-08-11 | 13G | STRUCTURE THERAPEUTICS INC SPO GPCR | BIOTECHNOLOGY VALUE FUND L P | 9,611,751 5.600% | 7,172,787 (+294.09%) | Filing History |
| 2025-08-14 4:07 pm Sale | 2025-06-30 | 13G | VIGIL NEUROSCIENCE INC VIGL | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -4,734,500 (Position Closed) | Filing History |
| 2025-08-14 4:06 pm Sale | 2025-06-30 | 13G | VERVE THERAPEUTICS INC VERV | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -6,904,050 (Position Closed) | Filing History |